Minovia Minovia Therapeutics is a biotechnology company that uses cell therapy to treat mitochondrial diseases. | MRM Health MRM Health is a biopharmaceutical company focused on the discovery and development of therapeutics based on the human microbiome. | ![]() Garuda Therapeutics Garuda Therapeutics is a biotechnology company specializing in hematopoietic stem cell therapies that eliminates dependency on donor or patient cells. | ![]() Gyre Therapeutics Gyre Therapeutics (formerly known as Catalyst Biosciences) is a drug R&D company creating catalytic biopharmaceutical products based on engineered human proteases. | ![]() Cord Blood Registry Cord Blood Registry (CBR) is a company that specializes in the clinical application of cord blood and tissue stem cells. | |
Founding Date | Founding Date 2012 | Founding Date 2020 | Founding Date 2021 | Founding Date 2003 | Founding Date 1992 |
Type | Type Private | Type Private | Type Private | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations טירת כרמל, IL HQ | Locations Gent, BE HQ | Locations Cambridge, US HQ | Locations South San Francisco, US HQ | Locations Los Angeles, US HQ Tucson, US Chicago, US |
Employees | Employees 28 | Employees 422% increase | Employees 6311% increase | Employees 3462% increase | Employees 169 |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 72m | Total funding raised $ 30m | Total funding raised $ 18m |
MRM Health is a biopharmaceutical company focused on the discovery and development of therapeutics based on the human microbiome.
View company
Garuda Therapeutics is a biotechnology company specializing in hematopoietic stem cell therapies that eliminates dependency on donor or patient cells.
View company
Gyre Therapeutics (formerly known as Catalyst Biosciences) is a drug R&D company creating catalytic biopharmaceutical products based on engineered human proteases.
View company
Cord Blood Registry (CBR) is a company that specializes in the clinical application of cord blood and tissue stem cells.
View company